Found 45 matching trials
The Energetic Origin of Neurodegeneration in MS NA In multiple sclerosis (MS), the sequence of events leading to irreversible ...
Show More Location
ICM, Hôpital Pitié Salpêtrière, 47 Boulevard de l'Hôpital
Learn More & Join Trial
Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma PHASE2 This phase II trial tests how well giving dasatinib and quercetin with cycl...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer PHASE1 This phase I clinical trial evaluates the safety and feasibility of adminis...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
Application of Multimodal MRI-based Radiomics in Histological Grading and Prognostic Assessment of Breast Cancer N/A In addition to TNM staging, the current management of breast cancer is base...
Show More Location
Multiple Locations
Learn More & Join Trial
Assessment of Changes in Metabolic Activity in Liver & Skeletal Muscle in Patients Suffering From Acromegaly N/A Growth hormone (GH) plays a pivotal role in the regulation of body composit...
Show More Location
Medical University Of Vienna, Department of Internal Medicine III
Learn More & Join Trial
Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia PHASE2 This phase II trial tests how well etoposide, prednisone, vincristine, cycl...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Functional Imaging of T-Cell Activation With [18F]F-AraG in Urothelial Carcinoma Patients Receiving Neoadjuvant Therapy or Patients With Cancer Receiving Standard of Care Anti-PD-1/L1 PHASE2 This phase II trial studies how well fluorine F 18 Ara-G positron emission ...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL) PHASE2 This phase II trial tests the safety and effectiveness of giving chemothera...
Show More Location
Multiple Locations
Learn More & Join Trial
Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy PHASE1 Background:
Multiple sclerosis (MS) and progressive multifocal leukoenceph...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Longitudinal Assessment of Iron Rims in MS Lesions N/A In multiple sclerosis (MS), the presence of white matter lesions surrounded...
Show More Location
Nottingham University NHS Trust
Learn More & Join Trial